Cargando…
Baseline characteristics and age-related macular degeneration in participants of the “ASPirin in Reducing Events in the Elderly” (ASPREE)-AMD trial
PURPOSE: To describe the baseline participant characteristics in the ASPREE-AMD study, investigating the effect of aspirin on AMD incidence and progression. METHODS: Australian participants from the ASPirin in Reducing Events in the Elderly (ASPREE) trial, randomized to 100 mg aspirin daily or place...
Autores principales: | Robman, Liubov D., Phuong Thao, Le Thi, Guymer, Robyn H., Wolfe, Rory, Woods, Robyn L., Hodgson, Lauren AB., Phung, James, Makeyeva, Galina A., Le-Pham, Y-Anh, Orchard, Suzanne G., Suleiman, Jewhara, Maguire, Emily, Trevaks, Ruth E., Ward, Stephanie A., Riaz, Moeen, Lacaze, Paul, Storey, Elsdon, Abhayaratna, Walter P., Nelson, Mark R., Ernst, Michael E., Reid, Christopher M., McNeil, John J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7658662/ https://www.ncbi.nlm.nih.gov/pubmed/33210016 http://dx.doi.org/10.1016/j.conctc.2020.100667 |
Ejemplares similares
-
Age-related macular degeneration in a randomized controlled trial of low-dose aspirin: Rationale and study design of the ASPREE-AMD study
por: Robman, Liubov, et al.
Publicado: (2017) -
Expanded statistical analysis plan for legacy and long-term effects of aspirin in the ASPREE-XT observational follow-up study of participants in the ASPREE randomized trial
por: Wolfe, Rory, et al.
Publicado: (2023) -
ASPREE SUB-STUDIES
por: Woods, Robyn L, et al.
Publicado: (2019) -
Overcoming challenges to data quality in the ASPREE clinical trial
por: Lockery, Jessica E., et al.
Publicado: (2019) -
Development of a standardized definition for clinically significant bleeding in the ASPirin in Reducing Events in the Elderly (ASPREE) trial
por: Margolis, Karen L., et al.
Publicado: (2018)